Your shopping cart is currently empty

SHU 9119 is an effective human melanocortin 3 and 4 receptors (MC3/4R) antagonist and a partial MC5R agonist (IC50: 0.23, 0.06, and 0.09 nM for human MC3R, MC4R and MC5R, respectively).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 500 μg | $279 | 35 days | 35 days | |
| 1 mg | $429 | 35 days | 35 days |
| Description | SHU 9119 is an effective human melanocortin 3 and 4 receptors (MC3/4R) antagonist and a partial MC5R agonist (IC50: 0.23, 0.06, and 0.09 nM for human MC3R, MC4R and MC5R, respectively). |
| Targets&IC50 | MC5R:0.23 nM, MC3R:0.23 nM, MC4R:0.23 nM |
| In vivo | SHU9119 treatment significantly enhances metabolic efficiency by increasing mRNA levels of genes involved in lipogenesis and TAG storage in adipocytes, including stearoyl-CoA desaturase-1, lipoprotein lipase, acetyl-CoA carboxylase α, and fatty acid synthase. Chronic intracerebroventricular infusion of SHU9119 (24 nmol/d for 7 days) in ad libitum-fed rats increases food intake and weight gain compared to control. SHU9119 results in a 30% increase in food intake, a 50% increase in body fat, and a 42% reduction in energy expenditure due to decreased fat oxidation. It hampers VLDL-TG uptake and reduces uncoupling protein-1 levels in BAT by 60%, causing large intracellular lipid droplets and severely disturbed BAT activity [2][3]. |
| Molecular Weight | 1074.258 |
| Formula | C54H71N15O9 |
| Cas No. | 168482-23-3 |
| Smiles | CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)C(N)=O |
| Relative Density. | 1.43 g/cm3 |
| Sequence | Ac-{Nle}-Asp-His-{d-Nal}-Arg-Trp-Lys-NH2 (Lactam bridge: Asp2-Lys7) |
| Sequence Short | {Nle}-DH-{d-Nal}-RWK (Lactam bridge: Asp2-Lys7) |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | H2O: 20 mg/mL (18.62 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
H2O
| |||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.